1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nuclear Imaging Devices Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Nuclear Imaging Device Market Analysis and Forecasts, 2017 – 2031
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. Regulatory Scenario
    5.2. Technological Advancements
    5.3. Key Industry Events
    5.4. COVID-19 Pandemic Impact on Industry
6. Global Nuclear Imaging Devices Market Analysis and Forecast, by Product Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Product Type, 2017 – 2031
        6.3.1. PET Devices
            6.3.1.1. Standalone PET
            6.3.1.2. PET/CT
            6.3.1.3. PET/MRI
        6.3.2. SPECT Devices
            6.3.2.1. Standalone SPECT
            6.3.2.2. SPECT/CT
            6.3.2.3. SPECT/MRI
        6.3.3. Planar Imaging Devices
    6.4. Market Attractiveness Analysis, by Product Type
7. Global Nuclear Imaging Devices Market Analysis and Forecast, by Application
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Application, 2017 – 2031
        7.3.1. Oncology
        7.3.2. Cardiology
        7.3.3. Neurology
        7.3.4. Others (Nephrology, Immunology, etc.)
    7.4. Market Attractiveness Analysis, by Application
8. Global Nuclear Imaging Devices Market Analysis and Forecast, by End-user
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by End-user, 2017 – 2031
        8.3.1. Hospitals
        8.3.2. Imaging Centers
        8.3.3. Academic and Research Centers
        8.3.4. Others (Clinics, CROs, etc.)
    8.4. Market Attractiveness Analysis, by End-user
9. Global Nuclear Imaging Devices Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region, 2017 – 2031
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region
10. North America Nuclear Imaging Devices Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Product Type, 2017 – 2031
        10.2.1. PET Devices
            10.2.1.1. Standalone PET
            10.2.1.2. PET/CT
            10.2.1.3. PET/MRI
        10.2.2. SPECT Devices
            10.2.2.1. Standalone SPECT
            10.2.2.2. SPECT/CT
            10.2.2.3. SPECT/MRI
        10.2.3. Planar Imaging Devices
    10.3. Market Value Forecast, by Application, 2017 – 2031
        10.3.1. Oncology
        10.3.2. Cardiology
        10.3.3. Neurology
        10.3.4. Others (Nephrology, Immunology, etc.)
    10.4. Market Value Forecast, by End-user, 2017 – 2031
        10.4.1. Hospitals
        10.4.2. Imaging Centers
        10.4.3. Academic and Research Centers
        10.4.4. Others (Clinics, CROs, etc.)
    10.5. Market Value Forecast, by Country, 2017 – 2031
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Product Type
        10.6.2. By Application
        10.6.3. By End-user
        10.6.4. By Country
11. Europe Nuclear Imaging Devices Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product Type, 2017 – 2031
        11.2.1. PET Devices
            11.2.1.1. Standalone PET
            11.2.1.2. PET/CT
            11.2.1.3. PET/MRI
        11.2.2. SPECT Devices
            11.2.2.1. Standalone SPECT
            11.2.2.2. SPECT/CT
            11.2.2.3. SPECT/MRI
        11.2.3. Planar Imaging Devices
    11.3. Market Value Forecast, by Application, 2017 – 2031
        11.3.1. Oncology
        11.3.2. Cardiology
        11.3.3. Neurology
        11.3.4. Others (Nephrology, Immunology, etc.)
    11.4. Market Value Forecast, by End-user, 2017 – 2031
        11.4.1. Hospitals
        11.4.2. Imaging Centers
        11.4.3. Academic and Research Centers
        11.4.4. Others (Clinics, CROs, etc.)
    11.5. Market Value Forecast, by Country/Sub-region, 2017 – 2031
        11.5.1. Germany
        11.5.2. UK
        11.5.3. France
        11.5.4. Italy
        11.5.5. Spain
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Product Type
        11.6.2. By Application
        11.6.3. By End-user
        11.6.4. By Country/Sub-region
12. Asia Pacific Nuclear Imaging Devices Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product Type, 2017 – 2031
        12.2.1. PET Devices
            12.2.1.1. Standalone PET
            12.2.1.2. PET/CT
            12.2.1.3. PET/MRI
        12.2.2. SPECT Devices
            12.2.2.1. Standalone SPECT
            12.2.2.2. SPECT/CT
            12.2.2.3. SPECT/MRI
        12.2.3. Planar Imaging Devices
    12.3. Market Value Forecast, by Application, 2017 – 2031
        12.3.1. Oncology
        12.3.2. Cardiology
        12.3.3. Neurology
        12.3.4. Others (Nephrology, Immunology, etc.)
    12.4. Market Value Forecast, by End-user, 2017 – 2031
        12.4.1. Hospitals
        12.4.2. Imaging Centers
        12.4.3. Academic and Research Centers
        12.4.4. Others (Clinics, CROs, etc.)
    12.5. Market Value Forecast, by Country/Sub-region, 2017 – 2031
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Product Type
        12.6.2. By Application
        12.6.3. By End-user
        12.6.4. By Country/Sub-region
13. Latin America Nuclear Imaging Devices Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product Type, 2017 – 2031
        13.2.1. PET Devices
            13.2.1.1. Standalone PET
            13.2.1.2. PET/CT
            13.2.1.3. PET/MRI
        13.2.2. SPECT Devices
            13.2.2.1. Standalone SPECT
            13.2.2.2. SPECT/CT
            13.2.2.3. SPECT/MRI
        13.2.3. Planar Imaging Devices
    13.3. Market Value Forecast, by Application, 2017 – 2031
        13.3.1. Oncology
        13.3.2. Cardiology
        13.3.3. Neurology
        13.3.4. Others (Nephrology, Immunology, etc.)
    13.4. Market Value Forecast, by End-user, 2017 – 2031
        13.4.1. Hospitals
        13.4.2. Imaging Centers
        13.4.3. Academic and Research Centers
        13.4.4. Others (Clinics, CROs, etc.)
    13.5. Market Value Forecast, by Country/Sub-region, 2017 – 2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Product Type
        13.6.2. By Application
        13.6.3. By End-user
        13.6.4. By Country/Sub-region
14. Middle East & Africa Nuclear Imaging Devices Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Product Type, 2017 – 2031
        14.2.1. PET Devices
            14.2.1.1. Standalone PET
            14.2.1.2. PET/CT
            14.2.1.3. PET/MRI
        14.2.2. SPECT Devices
            14.2.2.1. Standalone SPECT
            14.2.2.2. SPECT/CT
            14.2.2.3. SPECT/MRI
        14.2.3. Planar Imaging Devices
    14.3. Market Value Forecast, by Application, 2017 – 2031
        14.3.1. Oncology
        14.3.2. Cardiology
        14.3.3. Neurology
        14.3.4. Others (Nephrology, Immunology, etc.)
    14.4. Market Value Forecast, by End-user, 2017 – 2031
        14.4.1. Hospitals
        14.4.2. Imaging Centers
        14.4.3. Academic and Research Centers
        14.4.4. Others (Clinics, CROs, etc.)
    14.5. Market Value Forecast, by Country/Sub-region, 2017 – 2031
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Product Type
        14.6.2. By Application
        14.6.3. By End-user
        14.6.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player – Competition Matrix (By Tier and Size of Companies)
    15.2. Market Share Analysis, by Company (2022)
    15.3. Company Profiles
        15.3.1. Koninklijke Philips N.V.
            15.3.1.1. Company Overview
            15.3.1.2. Financial Overview
            15.3.1.3. Product Portfolio
            15.3.1.4. Business Strategies
            15.3.1.5. Recent Developments
        15.3.2. GE Healthcare
            15.3.2.1. Company Overview
            15.3.2.2. Financial Overview
            15.3.2.3. Product Portfolio
            15.3.2.4. Business Strategies
            15.3.2.5. Recent Developments
        15.3.3. Canon Medical Systems Corporation
            15.3.3.1. Company Overview
            15.3.3.2. Financial Overview
            15.3.3.3. Product Portfolio
            15.3.3.4. Business Strategies
            15.3.3.5. Recent Developments
        15.3.4. Siemens Healthineers AG
            15.3.4.1. Company Overview
            15.3.4.2. Financial Overview
            15.3.4.3. Product Portfolio
            15.3.4.4. Business Strategies
            15.3.4.5. Recent Developments
        15.3.5. Shimadzu Corporation
            15.3.5.1. Company Overview
            15.3.5.2. Financial Overview
            15.3.5.3. Product Portfolio
            15.3.5.4. Business Strategies
            15.3.5.5. Recent Developments
        15.3.6. MR Solutions
            15.3.6.1. Company Overview
            15.3.6.2. Financial Overview
            15.3.6.3. Product Portfolio
            15.3.6.4. Business Strategies
            15.3.6.5. Recent Developments
        15.3.7. Neusoft Medical Systems Co., Ltd.
            15.3.7.1. Company Overview
            15.3.7.2. Financial Overview
            15.3.7.3. Product Portfolio
            15.3.7.4. Business Strategies
            15.3.7.5. Recent Developments
        15.3.8. Mediso Ltd.
            15.3.8.1. Company Overview
            15.3.8.2. Financial Overview
            15.3.8.3. Product Portfolio
            15.3.8.4. Business Strategies
            15.3.8.5. Recent Developments
        15.3.9. MiE GmbH
            15.3.9.1. Company Overview
            15.3.9.2. Financial Overview
            15.3.9.3. Product Portfolio
            15.3.9.4. Business Strategies
            15.3.9.5. Recent Developments
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			